|
|
|
|
Focus On: Exubera An Orally inhaled insulin
Long-term glycemic control substantially reduces the risk of diabetes mellitus-related complications. Insulin is a mainstay in therapy in type 1 and later-stage type 2 diabetes mellitus. Although insulin is effective in controlling blood glucose and hemoglobin A1c concentrations, the need for subcutaneous injection can be a burden for patients, which can impact compliance. Exubera (Nektar Therapeutics/Pfizer/Sanofi-Aventis) is an inhaled insulin that has demonstrated results similar to conventional short-acting insulin products while also increasing overall patient satisfaction.
|
| |
More>>
|
|
|
|
|
|
Interactions between ginseng and prescription medications
Ginseng has been recommended for a wide variety of uses including amelioration of physical and mental performance, but there is little evidence of its efficacy. Evidence shows that it has some value in infection resistance, reducing stress, lowering cholesterol and blood sugar levels, and has a modest estrogen-like effect on women.
|
| |
More>>
|
|
|
|
|
|
Pharmacologic options for the management of diabetic peripheral neuropathy
Diabetic peripheral neuropathy, one of the most common late complications of diabetes, is associated with decreased quality of life and increased morbidity. The pathophysiology of diabetic neuropathy (DN) is multifactorial, contributing to ischemic and painful events and neuronal damage.
|
| |
More>>
|
|
|
|
|
|
Drugs and Race: Targeting medication to racial groups—what the future holds and why it's controversial
The Food & Drug Administration's recent approval of isosorbide dinitrate/hydralazine in African-Americans left some clinicians and civil rights groups scratching their heads. Was it a good or bad thing to target a drug to a specific race?
|
| |
More>>
|
|
|
